Infographic | March 10, 2023

mRNA Process And Cost Modeling: A Tool To Optimize Process Development

Financial Graph GettyImages-913219882

The COVID-19 pandemic brought into focus the impact that mRNA technology can have on rapid drug development. mRNA is an attractive modality to work with because of its relative simplicity compared to other biologics; it is wholly synthetic and does not require cellular materials.

Demand for mRNA-based medicine production in lower income countries continues to increase, as do investments in prophylactic and therapeutic indications, such as infectious diseases and cancer.

Explore a cost-model that compares all vaccine modalities, such as virus-like particles, viral vectors, and mRNA. This cost modeling approach enables decision making on production scale and plant sizing. In addition to several aspects of the cost-model, learn about ways to meet forecasted mRNA demand.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online